Current challenges surrounding exosome treatments

Eileen Tzng1, Nathan Bayardo1, Phillip C Yang1

  • 1Division of Cardiovascular Medicine and Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States of America.

Extracellular Vesicle
|March 3, 2025
PubMed

Insights

Exosomes show promise for treating cardiovascular disease by improving heart function after injury. Challenges in exosome therapy, including standardization and clinical application, require further research for effective precision medicine.

Area of Science:

  • Cardiovascular research
  • Regenerative medicine
  • Biotechnology

Background:

  • Cardiovascular disease is a leading global cause of mortality.
  • Exosomes demonstrate potential in improving cardiac function post-myocardial injury.
  • Exosome therapy offers a precision medicine approach by targeting disease mechanisms.

Purpose of the Study:

  • To explore the therapeutic potential of exosome therapy for cardiovascular diseases.
  • To address key challenges hindering the clinical application of exosome therapy.
  • To summarize biological plausibility, delivery, dosing, pharmacokinetics, and manufacturing of exosomes.

Main Methods:

  • Review of existing studies on exosome therapy for cardiovascular conditions.
  • Analysis of challenges including zeta potential, standardization, and regulation.
  • Focus on microRNA as a critical molecular cargo within exosomes.

Main Results:

  • Exosomes exhibit multiple mechanisms to enhance cardiac function after myocardial injury.
  • Significant challenges exist for the clinical translation of exosome therapy.
  • MicroRNA content is crucial for exosome-mediated therapeutic effects.

Conclusions:

  • Exosome therapy holds significant promise for cardiovascular disease treatment.
  • Overcoming challenges in standardization, manufacturing, and clinical application is essential.
  • Further research is needed to optimize exosome-based precision medicine for cardiac repair.